$AME

Ametek: Q3 Earnings Snapshot

Ametek Inc. (AME) reported Q3 net income of $426.3M, or $1.85 per share, beating estimates. Revenue was $2.22B, also surpassing forecasts. The company projects Q4 EPS of $2.26-$2.30 and full-year EPS of $8.53-$8.57. Shares are up 18% YTD and 20% over 12 months.

Original reporting
Published Nov 3, 2026, 12:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 12:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ametek: Q3 Earnings Snapshot — source image
Decision brief

The 30-second read

$AMEBullishMed
01

Why it matters

The combination of Q3 EPS and revenue beats plus explicit Q4 and full-year EPS guidance can drive earnings estimate revisions and near-term re-rating.

02

Market read

Traders can update AME’s earnings expectations immediately using the reported EPS/revenue beats and the stated EPS ranges for the December quarter and full year.

03

What to watch

The article omits segment performance, backlog, margin commentary, and cash flow details, which can be key for sustaining post-earnings moves beyond the headline EPS and revenue beats.

Relevance 9/10Novelty 8/10Timing: reported Tuesday, with Q4 and full-year EPS guidance for immediate repricing

Background

This is a first-report style earnings snapshot from AP/Automated Insights, citing Zacks consensus expectations.

Company-level read

Ticker impact

$AMEBullishHigh confidence
Context

Ametek reported Q3 net income of $426.3M, EPS $1.85 vs adjusted $2.21, and revenue $2.22B, topping analyst estimates, plus issued Q4 and FY EPS guidance.

Expected impact

Likely upward bias as the market prices in stronger-than-expected results and the company’s EPS guidance range.

Evidence & confidence

The article provides specific Q3 EPS and revenue beats versus consensus and includes explicit Q4 and FY EPS ranges, which are direct drivers for earnings revisions and near-term positioning.

Market effects

Supports sentiment for industrial instrumentation/electromechanical demand expectations, though no sector-wide read-across is provided.

Limited, as the story is company-specific with no broader regional macro or peer linkage.

Low, since the article contains no international demand, supply-chain, or geopolitical drivers.

Counterpoint

The guidance ranges may still be viewed as incremental rather than a major upside surprise, so upside may fade if investors focus on margins or segment trends not discussed here.

Key entities

  • Ametek Inc.

    Electronic instruments and electromechanical devices maker reporting Q3 results and issuing Q4 and full-year EPS guidance.

Related articles

$AMEHighAI 9/10

AMETEK Posts Record Q3 Sales and Adjusted EPS, Raises 2026 Guidance

AMETEK reported Q3 2026 sales of $2.22B, up 17% YoY, and adjusted EPS of $2.21. GAAP EPS was $1.85, with net income at $426.3M. The company raised its full-year adjusted EPS outlook to $8.53–$8.57. Growth was driven by organic sales, acquisitions, and strong demand across its businesses. AMETEK also completed the acquisition of Indicor Instrumentation.

$AMEHighAI 9/10

AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance

AMETEK INC/ (AME) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance Berwyn, Pa., Nov 3, 2026 – AMETEK, Inc. (NYSE: AME) today announced its financial results for the third quarter ended September 30, 2026. AMETEK’s third quarter 2026 sales were a record

$AMEMedAI 8/10

AMETEK Boosts FY26 Outlook - Update

AMETEK (AME) reported Q3 results and raised its FY26 outlook. Q4 adjusted earnings are expected to be $2.26-$2.30 per share with net sales growth in the low 20% range. FY26 adjusted earnings are now projected to be $8.53-$8.57 per share with mid-teen percentage net sales growth, up from previous guidance of $8.20-$8.30 per share. AME stock is up 0.86% in pre-market trading.

$AMEMedAI 9/10

AMETEK’s (NYSE:AME) Q3 2026 sales beat estimates

AMETEK reported Q3 2026 revenue of $2.22 billion, exceeding estimates by 2.9% and growing 17.3% year-on-year. Adjusted EPS was $2.21, beating estimates by 4.8%. Management raised full-year adjusted EPS guidance to $8.55 at the midpoint, a 3.6% increase. Operating margin remained steady at 26.3%, while free cash flow margin improved to 23.8% from 22.2% year-on-year.